Pharmaceuticals-Drugs Archives - Los Angeles Business Journal

News

Arrowhead Pharmaceuticals Receives $25M Payment

Antonio Pequeño IV - December 21, 2022

Pharmaceuticals-Drugs

ImmunityBio Investors Buoyed by News Company Preparing to Submit First Therapeutic for FDA Approval

HOWARD FINE - May 23, 2022

Medical Health

GoodRx Stock Plunges 26% After Issue With Grocery Chain Forces Company to Reduce Second Quarter Guidance

HOWARD FINE - May 16, 2022

Pharmaceuticals-Drugs

Battered Biotech Firm CytRx Hires New CEO, Retools

Howard Fine - April 25, 2022

Biotechnology

Ritter Pharma Raises $23 million to Test Lactose Intolerance Treatment

Dana Bartholomew - October 4, 2017

Pharmaceuticals-Drugs

Amgen Seeks Cholesterol Drug Approval

Business Journal Staff - August 28, 2014

Pharmaceuticals-Drugs

Amgen Gets FDA ‘Fast-Track’ Status

Business Journal Staff - August 27, 2014

Pharmaceuticals-Drugs

Amgen Announces Test Setback, Recall

Andrew Edwards - August 13, 2014

Pharmaceuticals-Drugs

Puma Shares Slip on Deeper Loss

Andrew Edwards - August 11, 2014

Pharmaceuticals-Drugs

Amgen Up on Drug Study

Business Journal Staff - August 4, 2014

Pharmaceuticals-Drugs

Amgen Announces Deep Job Cuts

Business Journal Staff - July 29, 2014

Pharmaceuticals-Drugs

Puma Shares Skyrocket

Andrew Edwards - July 23, 2014

Pharmaceuticals-Drugs

Amgen, Bind Therapeutics Cease Collaboration

Business Journal Staff - July 7, 2014

Pharmaceuticals-Drugs

Breakthrough Status for Amgen Leukemia Drug

Business Journal Staff - July 2, 2014

Pharmaceuticals-Drugs

MannKind Gets FDA Approval for Inhalable Insulin

Business Journal Staff - June 27, 2014

Pharmaceuticals-Drugs

Changes Breathe Life Into Amgen’s Zombie Shares

Bethany Firnhaber - September 2, 2012

Pharmaceuticals-Drugs

CytRx Shares Boosted From ‘Milestone’ Cancer Drug

Joel Russell - June 25, 2012

Pharmaceuticals-Drugs

Amgen Announces $5 Billion Buyback Plan

Joel Russell - November 7, 2011

Pharmaceuticals-Drugs

Simulations Plus Releases Preliminary Financials

Joel Russell - September 7, 2011

Pharmaceuticals-Drugs

Amgen Earnings Decline in Third Quarter

Joel Russell - October 25, 2010

Join Our Membership!

Pharmaceuticals-Drugs

Arrowhead Pharmaceuticals Receives $25M Payment

ImmunityBio Investors Buoyed by News Company Preparing to Submit First Therapeutic for FDA Approval

GoodRx Stock Plunges 26% After Issue With Grocery Chain Forces Company to Reduce Second Quarter Guidance

Battered Biotech Firm CytRx Hires New CEO, Retools

Ritter Pharma Raises $23 million to Test Lactose Intolerance Treatment

Amgen Seeks Cholesterol Drug Approval

Amgen Gets FDA ‘Fast-Track’ Status

Amgen Announces Test Setback, Recall

Puma Shares Slip on Deeper Loss

Amgen Up on Drug Study

Amgen Announces Deep Job Cuts

Puma Shares Skyrocket

Amgen, Bind Therapeutics Cease Collaboration

Breakthrough Status for Amgen Leukemia Drug

MannKind Gets FDA Approval for Inhalable Insulin

Changes Breathe Life Into Amgen’s Zombie Shares

CytRx Shares Boosted From ‘Milestone’ Cancer Drug

Amgen Announces $5 Billion Buyback Plan

Simulations Plus Releases Preliminary Financials

Amgen Earnings Decline in Third Quarter

Advertise with Us

About Us

Membership Center

Other Journals